CDB25:0004348 TAFA5 — S1PR2

Experimentally validated in Human, Mixed species; Orthology-inferred in Human, Mouse, Rat, Frog, Zebrafish, Chicken, Macaque, Pig, Dog, Cow, Chimp, Horse, Marmoset, Sheep

Title

Journal:; Year Published:

Abstract

Novel Adipokine, FAM19A5, Inhibits Neointima Formation After Injury Through Sphingosine-1-Phosphate Receptor 2.

Circulation, 2018; PubMed, Homo sapiens TAFA5 — Homo sapiens S1PR2
ABSTRACT: Obesity plays crucial roles in the development of cardiovascular diseases. However, the mechanisms that link obesity and cardiovascular diseases remain elusive. Compelling evidence indicates that adipokines play an important role in obesity-related cardiovascular diseases. Here, we found a new adipokine-named family with sequence similarity 19, member A5 (FAM19A5), a protein with unknown function that was predicted to be distantly related to the CC-chemokine family. We aimed to test whether adipose-derived FAM19A5 regulates vascular pathology on injury.
Basic Information on TAFA5
Ligand Name: TAFA chemokine like family member 5
Other Symbols: FAM19A5, TAFA-5
Ligand Location: secreted based on perplexity, uniprot
HGNC Gene Symbol Report: TAFA5
GeneCards: TAFA5
Interactions with other Receptors for TAFA5
Basic Information on S1PR2
Receptor Name: sphingosine-1-phosphate receptor 2
Other Symbols: EDG5, DFNB68, Gpcr13, H218, AGR16
Receptor Location: cell membrane based on perplexity, uniprot
HGNC Gene Symbol Report: S1PR2
GeneCards: S1PR2
HGNC Gene Group: 7TM proteins
Interactions with other Ligands for S1PR2